FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012040645> ?p ?o ?g. }

• W2012040645 endingPage "1537" @default.
• W2012040645 startingPage "1525" @default.
• W2012040645 abstract "The causes of neurodegeneration are not well understood. However, the role of environmental and endogenous toxins is receiving much attention. In this study, we compared the synthetic neurotoxin 1-methyl-4-phenyl-pyridinium with β-carbolines occurring in human brain. Methylation of both nitrogens is necessary to convert a β-carboline into a potent inhibitor of mitochondrial complex I. The respective β-carboline, 2,9-dimethyl-β-carbolinium ion is neurotoxic in rats. To investigate the underlying mechanisms, we incubated mouse neuroblastoma 2A cells with 2,9-dimethyl-β-carbolinium ion, and compared the findings with effects of norharman, the precursor β-carboline of methylated derivatives, and with 1-methyl-4-phenyl-pyridinium. 2,9-Dimethyl-β-carbolinium ion caused a significant increase of reactive oxygen species (higher efficiency than 1-methyl-4-phenyl-pyridinium) and of mitochondrial membrane potential within the first minutes. After 60 min, the membrane potential dissipated. Concomitantly, the levels of glutathione increased in 2,9-dimethyl-β-carbolinium ion but not in 1-methyl-4-phenyl-pyridinium treated cells. After 24 h effector caspases 3 and 7 were activated and the number of apoptotic cells increased as revealed by fluorescence-activated cell sorting cytometry. When incubated longer (48 h), cells underwent late apoptosis/secondary necrosis as shown by fluorescence-activated cell sorting analysis and confirmed qualitatively by an electron microscopy study. The effects of 2,9-dimethyl-β-carbolinium ion on apoptotic changes were similar to those induced by 1-methyl-4-phenyl-pyridinium, while norharman showed only a weak potency at the very high doses. To investigate whether 2,9-dimethyl-β-carbolinium ion is neurotoxic under in vivo conditions and whether only dopaminergic neurones are affected we conducted a dose-response study. Three weeks after injection of 2,9-dimethyl-β-carbolinium ion in the substantia nigra we found a dose-dependent decrease of dopamine and its metabolites in the striatum of rats. The levels of 5-hydroxytryptamine were diminished although the decrease was less. The levels of noradrenaline increased after some doses. The findings strongly suggest an important role of endogenous β-carbolines in neurodegeneration with apoptosis as the predominant mechanism." @default.
• W2012040645 created "2016-06-24" @default.
• W2012040645 creator A5000530451 @default.
• W2012040645 creator A5004881293 @default.
• W2012040645 creator A5008660103 @default.
• W2012040645 creator A5019720605 @default.
• W2012040645 creator A5047629043 @default.
• W2012040645 creator A5048770454 @default.
• W2012040645 creator A5055963680 @default.
• W2012040645 creator A5069815168 @default.
• W2012040645 creator A5073967965 @default.
• W2012040645 creator A5082844749 @default.
• W2012040645 date "2006-01-01" @default.
• W2012040645 modified "2023-10-03" @default.
• W2012040645 title "2,9-Dimethyl-β-carbolinium, a neurotoxin occurring in human brain, is a potent inducer of apoptosis as 1-methyl-4-phenylpyridinium" @default.
• W2012040645 cites W1554017667 @default.
• W2012040645 cites W1585781020 @default.
• W2012040645 cites W1600077014 @default.
• W2012040645 cites W1967766636 @default.
• W2012040645 cites W1969800514 @default.
• W2012040645 cites W1971389338 @default.
• W2012040645 cites W1972331889 @default.
• W2012040645 cites W1984778379 @default.
• W2012040645 cites W1986334064 @default.
• W2012040645 cites W1999731922 @default.
• W2012040645 cites W2001563231 @default.
• W2012040645 cites W2008757391 @default.
• W2012040645 cites W2021051334 @default.
• W2012040645 cites W2022841709 @default.
• W2012040645 cites W2027997916 @default.
• W2012040645 cites W2043236453 @default.
• W2012040645 cites W2045967817 @default.
• W2012040645 cites W2048005838 @default.
• W2012040645 cites W2048367257 @default.
• W2012040645 cites W2050357506 @default.
• W2012040645 cites W2050793037 @default.
• W2012040645 cites W2054190261 @default.
• W2012040645 cites W2057702770 @default.
• W2012040645 cites W2067038367 @default.
• W2012040645 cites W2068048197 @default.
• W2012040645 cites W2077330808 @default.
• W2012040645 cites W2083740534 @default.
• W2012040645 cites W2090180519 @default.
• W2012040645 cites W2093119033 @default.
• W2012040645 cites W2095004303 @default.
• W2012040645 cites W2134080855 @default.
• W2012040645 cites W2146889361 @default.
• W2012040645 cites W2152545053 @default.
• W2012040645 cites W2156241187 @default.
• W2012040645 cites W2157008395 @default.
• W2012040645 cites W32913599 @default.
• W2012040645 doi "https://doi.org/10.1016/j.neuroscience.2006.01.018" @default.
• W2012040645 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16517085" @default.
• W2012040645 hasPublicationYear "2006" @default.
• W2012040645 type Work @default.
• W2012040645 sameAs 2012040645 @default.
• W2012040645 citedByCount "22" @default.
• W2012040645 countsByYear W20120406452012 @default.
• W2012040645 countsByYear W20120406452013 @default.
• W2012040645 countsByYear W20120406452015 @default.
• W2012040645 countsByYear W20120406452016 @default.
• W2012040645 countsByYear W20120406452017 @default.
• W2012040645 crossrefType "journal-article" @default.
• W2012040645 hasAuthorship W2012040645A5000530451 @default.
• W2012040645 hasAuthorship W2012040645A5004881293 @default.
• W2012040645 hasAuthorship W2012040645A5008660103 @default.
• W2012040645 hasAuthorship W2012040645A5019720605 @default.
• W2012040645 hasAuthorship W2012040645A5047629043 @default.
• W2012040645 hasAuthorship W2012040645A5048770454 @default.
• W2012040645 hasAuthorship W2012040645A5055963680 @default.
• W2012040645 hasAuthorship W2012040645A5069815168 @default.
• W2012040645 hasAuthorship W2012040645A5073967965 @default.
• W2012040645 hasAuthorship W2012040645A5082844749 @default.
• W2012040645 hasConcept C1491633281 @default.
• W2012040645 hasConcept C153911025 @default.
• W2012040645 hasConcept C155647269 @default.
• W2012040645 hasConcept C181911157 @default.
• W2012040645 hasConcept C185592680 @default.
• W2012040645 hasConcept C190283241 @default.
• W2012040645 hasConcept C2777221202 @default.
• W2012040645 hasConcept C2778630268 @default.
• W2012040645 hasConcept C2780358027 @default.
• W2012040645 hasConcept C31573885 @default.
• W2012040645 hasConcept C55493867 @default.
• W2012040645 hasConcept C86803240 @default.
• W2012040645 hasConcept C98424977 @default.
• W2012040645 hasConceptScore W2012040645C1491633281 @default.
• W2012040645 hasConceptScore W2012040645C153911025 @default.
• W2012040645 hasConceptScore W2012040645C155647269 @default.
• W2012040645 hasConceptScore W2012040645C181911157 @default.
• W2012040645 hasConceptScore W2012040645C185592680 @default.
• W2012040645 hasConceptScore W2012040645C190283241 @default.
• W2012040645 hasConceptScore W2012040645C2777221202 @default.
• W2012040645 hasConceptScore W2012040645C2778630268 @default.
• W2012040645 hasConceptScore W2012040645C2780358027 @default.
• W2012040645 hasConceptScore W2012040645C31573885 @default.
• W2012040645 hasConceptScore W2012040645C55493867 @default.
• W2012040645 hasConceptScore W2012040645C86803240 @default.

• next